Premium
Trixeo Aerosphere: a triple‐combination inhaler for COPD
Author(s) -
Chaplin Steve
Publication year - 2021
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1957
Subject(s) - medicine , formoterol , inhaler , copd , budesonide , metered dose inhaler , adverse effect , budesonide/formoterol , dry powder inhaler , formoterol fumarate , asthma , anesthesia , pharmacology
Trixeo Aerosphere (formoterol/glycopyrronium/budesonide) is a metered‐dose triple‐combination inhaler for the treatment of moderate to severe COPD. This article summarises its indications, clinical trial efficacy and adverse effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom